JP2019213549A5 - - Google Patents

Download PDF

Info

Publication number
JP2019213549A5
JP2019213549A5 JP2019148806A JP2019148806A JP2019213549A5 JP 2019213549 A5 JP2019213549 A5 JP 2019213549A5 JP 2019148806 A JP2019148806 A JP 2019148806A JP 2019148806 A JP2019148806 A JP 2019148806A JP 2019213549 A5 JP2019213549 A5 JP 2019213549A5
Authority
JP
Japan
Prior art keywords
human
gene segment
mouse
genetically modified
immunoglobulin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019148806A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019213549A (ja
JP7010902B2 (ja
Filing date
Publication date
Priority claimed from US13/798,455 external-priority patent/US9796788B2/en
Application filed filed Critical
Publication of JP2019213549A publication Critical patent/JP2019213549A/ja
Publication of JP2019213549A5 publication Critical patent/JP2019213549A5/ja
Application granted granted Critical
Publication of JP7010902B2 publication Critical patent/JP7010902B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019148806A 2013-03-13 2019-08-14 限られた免疫グロブリン軽鎖レパートリーを発現するマウス Active JP7010902B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/798,455 2013-03-13
US13/798,455 US9796788B2 (en) 2010-02-08 2013-03-13 Mice expressing a limited immunoglobulin light chain repertoire

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2019006738A Division JP6790136B2 (ja) 2013-03-13 2019-01-18 限られた免疫グロブリン軽鎖レパートリーを発現するマウス

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020128111A Division JP2020182490A (ja) 2013-03-13 2020-07-29 限られた免疫グロブリン軽鎖レパートリーを発現するマウス

Publications (3)

Publication Number Publication Date
JP2019213549A JP2019213549A (ja) 2019-12-19
JP2019213549A5 true JP2019213549A5 (https=) 2020-09-10
JP7010902B2 JP7010902B2 (ja) 2022-02-10

Family

ID=50483561

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2016502035A Active JP6529957B2 (ja) 2013-03-13 2014-03-13 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2019006738A Active JP6790136B2 (ja) 2013-03-13 2019-01-18 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2019148806A Active JP7010902B2 (ja) 2013-03-13 2019-08-14 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2020128111A Pending JP2020182490A (ja) 2013-03-13 2020-07-29 限られた免疫グロブリン軽鎖レパートリーを発現するマウス

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016502035A Active JP6529957B2 (ja) 2013-03-13 2014-03-13 限られた免疫グロブリン軽鎖レパートリーを発現するマウス
JP2019006738A Active JP6790136B2 (ja) 2013-03-13 2019-01-18 限られた免疫グロブリン軽鎖レパートリーを発現するマウス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020128111A Pending JP2020182490A (ja) 2013-03-13 2020-07-29 限られた免疫グロブリン軽鎖レパートリーを発現するマウス

Country Status (26)

Country Link
EP (4) EP4545567A3 (https=)
JP (4) JP6529957B2 (https=)
KR (2) KR102424756B1 (https=)
CN (2) CN108611369B (https=)
AU (3) AU2014244020B2 (https=)
BR (1) BR112015022034B1 (https=)
CA (1) CA2903698C (https=)
CY (1) CY1121545T1 (https=)
DK (2) DK3501272T5 (https=)
ES (3) ES2712207T3 (https=)
FI (1) FI3501272T3 (https=)
HR (2) HRP20190706T1 (https=)
HU (2) HUE044003T2 (https=)
IL (2) IL240563B (https=)
LT (2) LT2967013T (https=)
MX (3) MX377146B (https=)
PL (2) PL3501272T3 (https=)
PT (2) PT2967013T (https=)
RS (2) RS64185B1 (https=)
RU (1) RU2689664C2 (https=)
SG (2) SG10201801101QA (https=)
SI (2) SI2967013T1 (https=)
SM (2) SMT201900196T1 (https=)
TR (1) TR201901668T4 (https=)
WO (1) WO2014160202A1 (https=)
ZA (2) ZA201505835B (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130045492A1 (en) 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
SMT202600080T1 (it) 2010-02-08 2026-03-09 Regeneron Pharma Topo con catena leggera comune
US9796788B2 (en) 2010-02-08 2017-10-24 Regeneron Pharmaceuticals, Inc. Mice expressing a limited immunoglobulin light chain repertoire
HUE047278T2 (hu) 2011-08-05 2020-04-28 Regeneron Pharma Humanizált univerzális könnyûláncú egerek
SG11201401181YA (en) 2011-10-17 2014-04-28 Regeneron Pharma Restricted immunoglobulin heavy chain mice
ME03551B (me) 2012-06-12 2020-07-20 Regeneron Pharma Humanizovane nehumane živoтinje sa ograničenim lokusima imunoglobulinskog тeškog lanca
MY178882A (en) * 2013-02-20 2020-10-21 Regeneron Pharma Non-human animals with modified immunoglobulin heavy chain sequences
CA3124228C (en) 2014-03-21 2024-05-14 Regeneron Pharmaceuticals, Inc. Non-human animals that make single domain binding proteins
CA2979702A1 (en) 2015-03-19 2016-09-22 Regeneron Pharmaceuticals, Inc. Non-human animals that select for light chain variable regions that bind antigen
KR20230006929A (ko) 2016-01-13 2023-01-11 리제너론 파마슈티칼스 인코포레이티드 조작된 중쇄 다양성 영역을 갖는 설치류
CA3076632A1 (en) * 2017-09-29 2019-04-04 Regeneron Pharmaceuticals, Inc. Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereof
IL318469A (en) 2018-06-14 2025-03-01 Regeneron Pharma Non-human animals capable of reorganizing transgenic DH-DH, and their uses
US12467062B2 (en) 2018-12-21 2025-11-11 Compass Therapeutics Llc Transgenic mouse expressing common human light chain
CA3125380A1 (en) 2019-02-18 2020-08-27 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animals with humanized immunoglobulin locus
BR112021016173A2 (pt) 2019-02-22 2021-11-03 Regeneron Pharma Roedor geneticamente modificado, métodos de produção de um roedor geneticamente modificado e de produção de um anticorpo anti-nav1.7, célula ou tecido isolado de roedor, linhagem celular imortalizada, embrião de roedor, construto de ácido nucleico de direcionamento, e, hibridoma
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물
JP2023529846A (ja) 2020-06-02 2023-07-12 バイオサイトジェン ファーマシューティカルズ (ベイジン) カンパニー リミテッド 共通軽鎖免疫グロブリン遺伝子座を有する遺伝子改変非ヒト動物
IL303865A (en) 2020-12-23 2023-08-01 Regeneron Pharma Methods for obtaining antibodies that bind transmembrane proteins and cells that produce them
CA3165366A1 (en) 2020-12-23 2022-06-30 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding anchor modified antibodies and uses thereof
CN114736927A (zh) * 2022-05-19 2022-07-12 东北大学 一种单抗克隆与表达载体的构建及应用
TW202430641A (zh) * 2023-01-18 2024-08-01 美商基利科學股份有限公司 人類免疫球蛋白二元輕鏈轉殖基因構築體及其用途
WO2026019824A1 (en) * 2024-07-16 2026-01-22 Gilead Sciences, Inc. Human immunoglobulin common light chain transgene constructs and uses thereof
CN121628915A (zh) * 2024-08-29 2026-03-10 上海泰槿生物技术有限公司 产生限制的免疫球蛋白轻链库的细胞、动物和方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041871B1 (en) * 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
US6737056B1 (en) 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7217797B2 (en) 2002-10-15 2007-05-15 Pdl Biopharma, Inc. Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
ES2473596T3 (es) * 2003-07-15 2014-07-07 Therapeutic Human Polyclonals, Inc. Loci de inmunoglobulina humanizada
ES2463476T3 (es) 2004-10-19 2014-05-28 Regeneron Pharmaceuticals, Inc. Método para generar un ratón homocigótico para una modificación genética
AU2007235496B2 (en) * 2006-03-31 2013-11-21 E. R. Squibb & Sons, L.L.C. Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
JP5307708B2 (ja) 2006-06-02 2013-10-02 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトil−6受容体に対する高親和性抗体
ITMI20071522A1 (it) * 2007-07-27 2009-01-28 Areta Internat S R L Vaccino idiotipico
EP2147594B1 (en) * 2008-06-27 2013-11-13 Merus B.V. Antibody producing non-human mammals
JP5827127B2 (ja) * 2008-12-18 2015-12-02 エラスムス・ユニヴァーシティ・メディカル・センター・ロッテルダム ヒト化抗体を発現する非ヒトトランスジェニック動物及びその使用
MY192182A (en) 2009-06-26 2022-08-04 Regeneron Pharma Readily isolated bispecific antibodies with native immunoglobulin format
US20120021409A1 (en) * 2010-02-08 2012-01-26 Regeneron Pharmaceuticals, Inc. Common Light Chain Mouse
US20130045492A1 (en) * 2010-02-08 2013-02-21 Regeneron Pharmaceuticals, Inc. Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
SMT202600080T1 (it) * 2010-02-08 2026-03-09 Regeneron Pharma Topo con catena leggera comune
PT3034608T (pt) * 2010-06-22 2019-05-28 Regeneron Pharma Ratinhos expressando uma cadeia leve híbrida de imunoglobulina com uma região variável humana
SMT201700023T1 (it) * 2010-08-02 2017-03-08 Regeneron Pharma Topi che producono proteine leganti vl
RU2460287C1 (ru) * 2011-03-29 2012-09-10 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО РГМУ Росздрава) Трансгенная мышь, предназначенная для моделирования состояний, угрожающих развитием синдрома внезапной сердечной смерти при дистрофин-дефицитной кардиомиопатии
HUE047278T2 (hu) * 2011-08-05 2020-04-28 Regeneron Pharma Humanizált univerzális könnyûláncú egerek
GB201122047D0 (en) * 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals

Similar Documents

Publication Publication Date Title
JP2019213549A5 (https=)
Kanki et al. High-efficiency CAG-FLPe deleter mice in C57BL/6J background
Muthamilarasan et al. Multi-omics approaches for strategic improvement of stress tolerance in underutilized crop species: a climate change perspective
Van de Weg et al. Epistatic fire blight resistance QTL alleles in the apple cultivar ‘Enterprise’and selection X-6398 discovered and characterized through pedigree-informed analysis
CN102638971B (zh) 动物模型及治疗分子
Kerdaffrec et al. Multiple alleles at a single locus control seed dormancy in Swedish Arabidopsis
JP2014110814A5 (https=)
Boichard et al. Experience from large scale use of the EuroGenomics custom SNP chip in cattle
JP2015502142A (ja) トランスジェニック非ヒトアッセイ脊椎動物、アッセイおよびキット
Li et al. Introgression of the Aegilops speltoides Su1-Ph1 suppressor into wheat
CN106028798A (zh) 用于创建良种品系的基于最优单倍体值的选择
Ori et al. Identification of QTL for live weight and growth rate using DNA markers on chromosome 3 in an F2 population of Japanese quail
Thompson et al. Lack of genetic introgression between wild and selectively bred Sydney rock oysters Saccostrea glomerata
JP2016509865A5 (https=)
Misra et al. Generation of single-copy transgenic mouse embryos directly from ES cells by tetraploid embryo complementation
JP2018506984A5 (https=)
JP2018522553A5 (https=)
Pavan et al. Map-vs. homology-based cloning for the recessive gene ol-2 conferring resistance to tomato powdery mildew
Nath et al. Analyses of crossbreeding parameters for juvenile body weight in broiler chicken
CN110547256A (zh) 肾脏足细胞特异敲除lncRNA DLX6-os1转基因小鼠的培育方法
Kawakami et al. Hybrid zones
Nath et al. Estimation of crossbreeding parameters for humoral response in broiler
Sargolzaei et al. Accuracy of a family-based genotype imputation algorithm
Hosur et al. Large-Scale Genome-Wide Optimization and Prediction of the Cre Recombinase System for Precise Genome Manipulation in Mice
Gedil et al. Biotechnology success stories by the Consultative Group on International Agriculture Research (CGIAR) system